Posted by Michael Wonder on 10 Aug 2018
August 2018 PBAC special meeting – public submissions now available
10 August 2018 - Public submissions to the August 2018 PBAC meeting regarding PD-1 and PD-L1 checkpoint inhibitor immunotherapies: options for subsidy consideration for multiple cancer types are now available.
The consultation process for the August 2018 PBAC special meeting - PD-1 and PD-L1 checkpoint inhibitor immunotherapies: options for subsidy consideration for multiple cancer types closed on 29 June 2018.
The Department appreciates the contribution of the 28 organisations and individuals who made a submission.
